When is a sentinel node biopsy indicated for patients with primary melanoma? An update of the 'Australian guidelines for the management of cutaneous melanoma'

Australas J Dermatol. 2017 Nov;58(4):274-277. doi: 10.1111/ajd.12662. Epub 2017 Jul 17.

Abstract

A sentinel lymph node biopsy is a surgical staging procedure performed for patients with primary cutaneous melanoma who are clinically lymph-node negative to determine whether there is low volume nodal metastasis in the draining lymph node field. A systematic review was recently performed to update the Australian clinical practice guidelines for the diagnosis and management of melanoma, addressing the question, 'When is a sentinel lymph node biopsy indicated?' This article discusses the findings of the systematic review and the evidence base for the updated guidelines.

Keywords: guidelines; melanoma; sentinel node biopsy.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Humans
  • Lymphatic Metastasis
  • Melanoma / secondary*
  • Melanoma / therapy
  • Neoplasm Staging
  • Patient Selection*
  • Practice Guidelines as Topic
  • Sentinel Lymph Node / pathology*
  • Sentinel Lymph Node Biopsy* / adverse effects
  • Skin Neoplasms / pathology*
  • Skin Neoplasms / therapy
  • Survival Rate